Literature DB >> 17170122

T-B+NK+ severe combined immunodeficiency caused by complete deficiency of the CD3zeta subunit of the T-cell antigen receptor complex.

Joseph L Roberts1, Jens Peter H Lauritsen, Myriah Cooney, Roberta E Parrott, Elisa O Sajaroff, Chan M Win, Michael D Keller, Jeffery H Carpenter, Juan Carabana, Michael S Krangel, Marcella Sarzotti, Xiao-Ping Zhong, David L Wiest, Rebecca H Buckley.   

Abstract

CD3zeta is a subunit of the T-cell antigen receptor (TCR) complex required for its assembly and surface expression that also plays an important role in TCR-mediated signal transduction. We report here a patient with T(-)B(+)NK(+) severe combined immunodeficiency (SCID) who was homozygous for a single C insertion following nucleotide 411 in exon 7 of the CD3zeta gene. The few T cells present contained no detectable CD3zeta protein, expressed low levels of cell surface CD3epsilon, and were nonfunctional. CD4(+)CD8(-)CD3epsilon(low), CD4(-)CD8(+)CD3epsilon(low), and CD4(-)CD8(-)CD3epsilon(low) cells were detected in the periphery, and the patient also exhibited an unusual population of CD56(-)CD16(+) NK cells with diminished cytolytic activity. Additional studies demonstrated that retrovirally transduced patient mutant CD3zeta cDNA failed to rescue assembly of nascent complete TCR complexes or surface TCR expression in CD3zeta-deficient MA5.8 murine T-cell hybridoma cells. Nascent transduced mutant CD3zeta protein was also not detected in metabolically labeled MA5.8 cells, suggesting that it was unstable and rapidly degraded. Taken together, these findings provide the first demonstration that complete CD3zeta deficiency in humans can cause SCID by preventing normal TCR assembly and surface expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17170122      PMCID: PMC1852234          DOI: 10.1182/blood-2006-08-043166

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  95 in total

1.  Onset of TCR-beta gene rearrangement and role of TCR-beta expression during CD3-CD4-CD8- thymocyte differentiation.

Authors:  D I Godfrey; J Kennedy; P Mombaerts; S Tonegawa; A Zlotnik
Journal:  J Immunol       Date:  1994-05-15       Impact factor: 5.422

2.  Crucial role of the pre-T-cell receptor alpha gene in development of alpha beta but not gamma delta T cells.

Authors:  H J Fehling; A Krotkova; C Saint-Ruf; H von Boehmer
Journal:  Nature       Date:  1995-06-29       Impact factor: 49.962

Review 3.  Selective events in T cell development.

Authors:  E Robey; B J Fowlkes
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

4.  Class II histocompatibility molecules associate with calnexin during assembly in the endoplasmic reticulum.

Authors:  K L Schreiber; M P Bell; C J Huntoon; S Rajagopalan; M B Brenner; D J McKean
Journal:  Int Immunol       Date:  1994-01       Impact factor: 4.823

Review 5.  T-cell repertoire diversity and clonal expansions in normal and clinical samples.

Authors:  C Pannetier; J Even; P Kourilsky
Journal:  Immunol Today       Date:  1995-04

6.  Role of TCR zeta chain in T cell development and selection.

Authors:  E W Shores; K Huang; T Tran; E Lee; A Grinberg; P E Love
Journal:  Science       Date:  1994-11-11       Impact factor: 47.728

7.  Developmental regulation of alpha beta T cell antigen receptor expression results from differential stability of nascent TCR alpha proteins within the endoplasmic reticulum of immature and mature T cells.

Authors:  K P Kearse; J L Roberts; T I Munitz; D L Wiest; T Nakayama; A Singer
Journal:  EMBO J       Date:  1994-10-03       Impact factor: 11.598

8.  T cell development in mice lacking the CD3-zeta/eta gene.

Authors:  M Malissen; A Gillet; B Rocha; J Trucy; E Vivier; C Boyer; F Köntgen; N Brun; G Mazza; E Spanopoulou
Journal:  EMBO J       Date:  1993-11       Impact factor: 11.598

9.  Abnormal T cell development in CD3-zeta-/- mutant mice and identification of a novel T cell population in the intestine.

Authors:  C P Liu; R Ueda; J She; J Sancho; B Wang; G Weddell; J Loring; C Kurahara; E C Dudley; A Hayday
Journal:  EMBO J       Date:  1993-12       Impact factor: 11.598

10.  Developmental and functional impairment of T cells in mice lacking CD3 zeta chains.

Authors:  H Ohno; T Aoe; S Taki; D Kitamura; Y Ishida; K Rajewsky; T Saito
Journal:  EMBO J       Date:  1993-11       Impact factor: 11.598

View more
  22 in total

Review 1.  The long quest for neonatal screening for severe combined immunodeficiency.

Authors:  Rebecca H Buckley
Journal:  J Allergy Clin Immunol       Date:  2012-01-24       Impact factor: 10.793

2.  Genotype, phenotype, and outcomes of nine patients with T-B+NK+ SCID.

Authors:  Grace P Yu; Kari C Nadeau; David R Berk; Geneviève de Saint Basile; Nathalie Lambert; Perrine Knapnougel; Joseph Roberts; Kristina Kavanau; Elizabeth Dunn; E Richard Stiehm; David B Lewis; Dale T Umetsu; Jennifer M Puck; Morton J Cowan
Journal:  Pediatr Transplant       Date:  2011-08-23

3.  Positive Family History, Infection, Low Absolute Lymphocyte Count (ALC), and Absent Thymic Shadow: Diagnostic Clues for All Molecular Forms of Severe Combined Immunodeficiency (SCID).

Authors:  Laurie M McWilliams; Mary Dell Railey; Rebecca H Buckley
Journal:  J Allergy Clin Immunol Pract       Date:  2015-03-29

4.  A leaky mutation in CD3D differentially affects αβ and γδ T cells and leads to a Tαβ-Tγδ+B+NK+ human SCID.

Authors:  Juana Gil; Elena M Busto; Beatriz Garcillán; Carmen Chean; Maria Cruz García-Rodríguez; Andrea Díaz-Alderete; Joaquín Navarro; Jesús Reiné; Angeles Mencía; Dolores Gurbindo; Cristina Beléndez; Isabel Gordillo; Marlena Duchniewicz; Kerstin Höhne; Félix García-Sánchez; Eduardo Fernández-Cruz; Eduardo López-Granados; Wolfgang W A Schamel; Miguel A Moreno-Pelayo; María J Recio; José R Regueiro
Journal:  J Clin Invest       Date:  2011-09-19       Impact factor: 14.808

5.  Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors.

Authors:  Enxiu Wang; Liang-Chuan Wang; Ching-Yi Tsai; Vijay Bhoj; Zack Gershenson; Edmund Moon; Kheng Newick; Jing Sun; Albert Lo; Timothy Baradet; Michael D Feldman; David Barrett; Ellen Puré; Steven Albelda; Michael C Milone
Journal:  Cancer Immunol Res       Date:  2015-05-04       Impact factor: 11.151

Review 6.  B-cell function in severe combined immunodeficiency after stem cell or gene therapy: a review.

Authors:  Rebecca H Buckley
Journal:  J Allergy Clin Immunol       Date:  2010-04       Impact factor: 10.793

7.  Zeta chain expression in T and NK cells in peripheral blood of children with nephrotic syndrome.

Authors:  Kinga Musiał; Lidia Ciszak; Agata Kosmaczewska; Aleksandra Szteblich; Irena Frydecka; Danuta Zwolińska
Journal:  Pediatr Nephrol       Date:  2009-10-15       Impact factor: 3.714

Review 8.  Genetics of SCID.

Authors:  Fausto Cossu
Journal:  Ital J Pediatr       Date:  2010-11-15       Impact factor: 2.638

9.  Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience.

Authors:  William T Shearer; Elizabeth Dunn; Luigi D Notarangelo; Christopher C Dvorak; Jennifer M Puck; Brent R Logan; Linda M Griffith; Donald B Kohn; Richard J O'Reilly; Thomas A Fleisher; Sung-Yun Pai; Caridad A Martinez; Rebecca H Buckley; Morton J Cowan
Journal:  J Allergy Clin Immunol       Date:  2013-11-28       Impact factor: 10.793

10.  Post-transplantation B cell function in different molecular types of SCID.

Authors:  Rebecca H Buckley; Chan M Win; Barry K Moser; Roberta E Parrott; Elisa Sajaroff; Marcella Sarzotti-Kelsoe
Journal:  J Clin Immunol       Date:  2012-09-22       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.